Free tool
Stocks near their 52-week high
We cover 104 companies trading within 5% of their own 52-week high. The median market value in the group is $2.59B. Across the group, the median move over the past trading day is +0.14%. 99% of the 101 with a 200-day average trade above it. Price change over the past year runs from +16.2% to +217.5% across the middle 80 percent of the group, with a median of +59.3%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
104 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| PFIZ34.SA | Pfizer Inc. | 36.48 BRL | +12.73% | +10.34% | +11.58% |
| BMYB34.SA | Bristol-Myers Squibb Company | 349.41 BRL | +12.49% | +17.24% | +40.74% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| A1RG34.SA | argenx SE | 209.16 BRL | +14.71% | +11.37% | +36.97% |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | 92.25 BRL | +2.81% | +12.61% | +18.03% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | 97.74 BRL | +24.04% | +17.29% | +94.70% |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% |
| QTS.DE | IQVIA Holdings Inc. | 222.10 EUR | +19.34% | +15.23% | −4.04% |
| I1LM34.SA | Illumina, Inc. | 232.57 BRL | +19.43% | +55.21% | +113.13% |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| BIIB34.SA | Biogen Inc. | 188.29 BRL | +9.47% | +16.95% | +47.86% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| I1NC34.SA | Incyte Corporation | 328.02 BRL | +11.19% | +18.38% | +41.91% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | 166.77 BRL | +12.08% | −0.14% | +4.97% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| T1CH34.SA | Bio-Techne Corporation | 12.60 BRL | +4.13% | +17.24% | +23.42% |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| SPTX | Seaport Therapeutics, Inc. | $27.84 | +39.90% | +40.32% | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| CRON.TO | Cronos Group Inc. | 4.95 CAD | +23.75% | +34.15% | +39.83% |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| KSI.TO | kneat.com, inc. | 6.50 CAD | +0.46% | +30.52% | +19.93% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| CGS.AX | Cogstate Limited | 3.20 AUD | +22.88% | +39.52% | +85.76% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| AVH.AX | AVITA Medical, Inc. | 2.87 AUD | +117.05% | +160.45% | +106.12% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,892.00 JPY | +4.82% | +10.10% | +21.78% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| EMPG | Empro Group Inc | $17.36 | 0.00% | 0.00% | +76.60% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| A2ZT34.SA | Azenta, Inc. | 14.16 BRL | +16.64% | +50.80% | +50.80% |
| SDI.AX | SDI Ltd | 1.40 AUD | 0.00% | +51.08% | +60.41% |
| ALECR.PA | Eurofins-Cerep SA | 17,700.00 EUR | +8.59% | −0.56% | −3.80% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| ENP.AX | Entropy Neurodynamics Limited | 0.04 AUD | +17.14% | +28.12% | +10.81% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% |
| BSLN.SW | Basilea Pharmaceutica AG | 65.30 CHF | +24.62% | +19.82% | +40.88% |
| SKAN.SW | SKAN Group AG | 65.70 CHF | +9.87% | +26.45% | +6.80% |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.